Grants and Contributions:
Title:
Noa Therapeutics Inc.-2025-2026-1039903
Agreement Number:
1039903
Agreement Value:
$10,275.00
Agreement Date:
Nov 18, 2025 - Apr 30, 2026
Description:
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
Organization:
National Research Council Canada
Expected Results:
Increase Canadian science and technological innovation and commercialization opportunities as measured by analysis of recipient performance reports and surveys.
Location:
Toronto, Ontario, CA M5G 1L7
Reference Number:
172-2025-2026-Q4-1039903
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
714319308
Recipient Type:
For-profit organization
Recipient's Operating Name:
Noa Therapeutics
Recipient's Legal Name:
Noa Therapeutics Inc.
Federal Riding Name:
University--Rosedale
Federal Riding Number:
35110
Program:
CanExport
Program Purpose:
The purpose of the CanExport Program is to build stronger and more competitive Canadian capacity to effectively compete in the global economy as set out in the New Trade and Investment Strategy. This is achieved by attracting foreign direct investment, by increasing Canadian innovation and commercialization opportunities, by increasing Canadian business’s share in foreign markets and by assisting Canadian Small and Medium-sized Enterprises (SMEs) seek to develop new export opportunities and markets.
NAICS Code:
54171